Matinas BioPharma Holdings's activity chart (see below) currently has 9 price targets and 13 ratings on display.
Analysts' price targets on this stock were met 12.5% of the time, taking 69.75 days on average.
Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 31-Oct-2024. First documented stock forecast 21-Nov-2016.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Nov-2016
$250
2 years 21 days ago
(31-Oct-2024)
0/2 (0%)
$202.2 (423.01%)
Buy Since 26-Jun-2019
$150
3 years 9 months 21 days ago
(31-Jan-2023)
0/2 (0%)
$95.5 (175.23%)
Buy Since 25-Aug-2020
$90
5 years 6 months 10 days ago
(11-May-2021)
0/2 (0%)
$3 (3.45%)
Buy Since 27-Jan-2020
$75
$150
6 years 7 months 21 days ago
(31-Mar-2020)
1/2 (50%)
$45 (150.00%)
279
What is MTNB (Matinas BioPharma Holdings) average time for price targets to be met?
Which analyst most recently updated their price target on MTNB (Matinas BioPharma Holdings)?
Which analyst has the lowest performance score on MTNB (Matinas BioPharma Holdings) with a proven track record?
Which analyst has the most public recommendations on MTNB (Matinas BioPharma Holdings)?
Which analyst is the currently most bullish on MTNB (Matinas BioPharma Holdings)?
Which analyst is the currently most reserved on MTNB (Matinas BioPharma Holdings)?